AzTrials
AzTrials

Post-Dural Puncture HeadachePDPHPatientsNCT06957899

Optic Nerve Sheath Diameter in Postspinal Headache

An observational study of Post-Dural Puncture Headache, run by Konya City Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to investigate the relationship between spinal needle size and optic nerve sheath diameter (ONSD) in patients who develop post-dural puncture headache (PDPH) after spinal anesthesia. ONSD is measured using ultrasound, which helps estimate changes in brain pressure. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Post-Dural Puncture Headache
How many people
40 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jul 2025to 5 Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population consists of adult patients aged 18 to 75 years who develop post-dural puncture headache (PDPH) following spinal anesthesia. All participants are evaluated and monitored at a tertiary care center and are classified as ASA physical status I to III.

Who may be able to join

  • Patients diagnosed with postdural puncture headache (PDPH)
  • Male and female patients aged 18-75 years
  • Patients classified as American Society of Anesthesiologists (ASA) physical status I-III

Who cannot join

  • Presence of neurological or ophthalmological disorders
  • History of head trauma within the past 6 months
  • Hypertension
  • Hepatic encephalopathy
  • Renal failure
  • Pregnancy
Show all 11Show fewer
  • History of chronic headache or migraine
  • Refusal to participate
  • Inability to obtain reliable optic nerve sheath diameter (ONSD) measurements
  • Communication difficulties preventing assessment
  • Incomplete or inaccessible medical records

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Konya City Hospital

    Meram, Konya, 42020

Other trials in Turkey (Türkiye)

About this study

Official title: Impact of Spinal Needle Gauge on Optic Nerve Sheath Diameter in Patients With Post-Dural Puncture Headache

This study aims to investigate the relationship between spinal needle size and optic nerve sheath diameter (ONSD) in patients who develop post-dural puncture headache (PDPH) after spinal anesthesia. ONSD is measured using ultrasound, which helps estimate changes in brain pressure. The study also examines whether the severity of headache is related to ONSD. Adult patients aged 18 to 75 years who develop PDPH will be included. This research will be conducted at Konya City Hospital and is expected to last for approximately six months.

Read the detailed description

This prospective observational study investigates the relationship between spinal needle gauge and optic nerve sheath diameter (ONSD) in patients who develop post-dural puncture headache (PDPH) following spinal anesthesia. ONSD is measured using ultrasound as a non-invasive marker of intracranial pressure. The study also aims to evaluate the association between headache severity, assessed by the Visual Analog Scale (VAS), and ONSD values. Patients aged 18-75 years with PDPH will be included, and data on spinal needle gauge, ONSD, and VAS scores will be analyzed. The study is being conducted at a single tertiary care center and aims to contribute to understanding the physiopathology of PDPH and its relation to procedural factors.

Keywords
Post-Dural Puncture Headache (PDPH), Intracranial Hypotension, Spinal Anesthesia Complication, Optic Nerve Sheath Diameter, Spinal Needle Gauge
Medical subject headings
Post-Dural Puncture Headache, Intracranial Hypotension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06957899
Study groupRoleWhat they receive
Group 25Group 25G: Patients who underwent spinal anesthesia with a 25-gauge needle
Group 27Group 27G: Patients who underwent spinal anesthesia with a 27-gauge needle

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Optic nerve sheath diameter (ONSD)

    The primary outcome is the measurement of optic nerve sheath diameter (ONSD) via ocular ultrasound in patients who develop postoperative headache attributed to dural puncture. This non-invasive assessment is used to estimate intracranial pressure. The aim is to evaluate whether different spinal needle gauges affect ONSD measurements.

    Measured: Within 4 hours of anesthesia consultation for postoperative headache

Secondary outcomes (1)
  1. Pain severity assessed by Visual Analog Scale (VAS)

    Pain severity will be scored using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain), during the anesthesia consultation conducted for postoperative headache. This measure will be compared with ONSD values.

    Measured: Within 4 hours of anesthesia consultation for postoperative headache

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 May 2025
  2. Study start1 Jul 2025
  3. Primary completion30 Sep 2025
  4. Study completion5 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06957899
Sponsor's protocol ID
2025/38
Acronym
PDPHPatients
Status last verified
May 2025
First submitted
12 Apr 2025
Last updated
9 Dec 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Wang P, Zhou X, Sheng F, Wang X, Shi C, Feng W. Ultrasonic optic nerve sheath diameter can be used as a diagnostic measure after accidental dural puncture during cesarean section: a case report. BMC Anesthesiol. 2024 Jan 22;24(1):35. doi: 10.1186/s12871-024-02418-8.

    PubMed 38254029
  • Dubost C, Le Gouez A, Zetlaoui PJ, Benhamou D, Mercier FJ, Geeraerts T. Increase in optic nerve sheath diameter induced by epidural blood patch: a preliminary report. Br J Anaesth. 2011 Oct;107(4):627-30. doi: 10.1093/bja/aer186. Epub 2011 Jun 21.

    PubMed 21693468

Questions about this trial

What is this clinical trial studying?

An observational study of Post-Dural Puncture Headache, run by Konya City Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Optic nerve sheath diameter (ONSD) (time frame: Within 4 hours of anesthesia consultation for postoperative headache). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06957899, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in